Funding Rounds
Tubulis

Tubulis Series B (2024, $139M)

Tubulis

Developer of chemotherapeutic drugs designed to fight against cancer and chronic diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $139.00M

Investors